Virax Biolabs Group Limited (VRAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRAX | AMGN | GILD | BMY | VRTX |
| Company | Virax Biolabs Group Limited | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 1.6700 | 261.10 | 93.43 | 57.65 | 405.26 |
| High | 2.1800 | 263.50 | 94.38 | 58.38 | 410.98 |
| Low | 1.6700 | 260.51 | 93.43 | 57.52 | 404.49 |
| Last | 2.1000 | 262.65 | 94.11 | 57.68 | 408.76 |
| Change | +0.3700 | -0.53 | -0.30 | -0.32 | -1.89 |
| % Change | +21.39% | -0.20% | -0.32% | -0.55% | -0.46% |
| Volume | 946,400 | 2,157,400 | 3,349,300 | 6,607,600 | 1,373,400 |
| 20-Day Average Volume | 430,860 | 4,008,790 | 6,989,885 | 11,231,390 | 1,844,190 |
| Previous Close | 1.7300 | 263.18 | 94.41 | 58.00 | 410.65 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.8100 | 270.30 | 92.54 | 57.75 | 446.39 |
| 20-Day Raw Stochastic | 67.66% | 30.82% | 90.18% | 52.29% | 31.35% |
| 20-Day Relative Strength | 53.27% | 32.42% | 58.23% | 53.49% | 34.61% |
| Weighted Alpha | -72.65 | -15.42 | +26.39 | +20.28 | -7.71 |
| Today's Opinion | 16% Buy | 88% Sell | 100% Buy | 80% Buy | 72% Sell |
| Previous Opinion | 32% Sell | 88% Sell | 100% Buy | 96% Buy | 72% Sell |
| Last Month's Opinion | 48% Buy | 72% Sell | 96% Buy | 100% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.11% since 12/19/24 | +0.56% since 12/19/24 | +3.32% since 12/19/24 | +2.45% since 12/19/24 | +3.06% since 12/19/24 |
| Low | 1.6200 on 12/24/24 | 260.51 on 12/27/24 | 90.71 on 12/20/24 | 56.08 on 12/20/24 | 386.49 on 12/20/24 |
| High | 2.1800 on 12/27/24 | 269.61 on 12/20/24 | 94.55 on 12/26/24 | 58.38 on 12/27/24 | 411.29 on 12/26/24 |
| 1-Month | |||||
| %Chg | +1.45% since 11/27/24 | -6.22% since 11/27/24 | +1.84% since 11/27/24 | -2.68% since 11/27/24 | -12.01% since 11/27/24 |
| Low | 1.5100 on 12/16/24 | 253.30 on 12/19/24 | 89.15 on 12/13/24 | 55.04 on 12/13/24 | 377.85 on 12/19/24 |
| High | 2.3800 on 12/18/24 | 283.64 on 11/29/24 | 94.65 on 12/11/24 | 60.09 on 12/03/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | +8.25% since 09/27/24 | -18.60% since 09/27/24 | +12.56% since 09/27/24 | +13.30% since 09/27/24 | -11.69% since 09/27/24 |
| Low | 1.4600 on 10/18/24 | 253.30 on 12/19/24 | 82.82 on 10/01/24 | 51.03 on 09/30/24 | 377.85 on 12/19/24 |
| High | 3.6200 on 10/23/24 | 329.17 on 10/11/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | +77.97% since 06/27/24 | -16.27% since 06/27/24 | +36.73% since 06/27/24 | +38.95% since 06/27/24 | -13.49% since 06/27/24 |
| Low | 0.9500 on 08/05/24 | 253.30 on 12/19/24 | 66.01 on 07/05/24 | 39.35 on 07/05/24 | 377.85 on 12/19/24 |
| High | 9.0000 on 08/19/24 | 346.85 on 07/25/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,593 | 141,467,936 | 117,659,984 | 117,634,272 | 105,754,280 |
| Shares Outstanding, K | 3,233 | 537,533 | 1,246,266 | 2,028,177 | 257,529 |
| Annual Sales | 160,000 | 28,190,000,000 | 27,116,000,000 | 45,006,000,000 | 9,869,200,000 |
| Annual Net Income | -6,730,000 | 6,717,000,000 | 5,665,000,000 | 8,025,000,000 | 3,619,600,000 |
| Last Quarter Sales | N/A | 8,503,000,000 | 7,545,000,000 | 11,892,000,000 | 2,771,900,000 |
| Last Quarter Net Income | N/A | 2,830,000,000 | 1,253,000,000 | 1,211,000,000 | 1,045,400,000 |
| 60-Month Beta | 1.84 | 0.55 | 0.18 | 0.45 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.58 on 10/30/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 11/19/24 | 02/04/25 | 02/11/25 | 02/06/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.770 on 12/13/24 | 0.600 on 10/04/24 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 12/13/24 | 01/03/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.76 | 21.21 | 49.37 | 0.00 |